 |
市场调查报告书
商品编码
1672939
水凝胶药物传输系统市场按来源、应用、输送途径、最终用户和地区划分Hydrogel-Based Drug Delivery System Market, By Source, By Application, By Route of Delivery, By End User, By Geography |
||||||
2025 年全球基于水凝胶的药物输送系统市场规模估计为 84.9 亿美元，预计到 2032 年将达到 134.7 亿美元，2025 年至 2032 年的复合年增长率为 6.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 84.9 亿美元 |
| 效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
| 预测期：2025-2032年复合年增长率： | 6.80% | 2032 年价值预测 | 134.7亿美元 |
基于水凝胶的药物递送系统是一种新兴技术，利用水凝胶作为药物包封和递送的载体。水凝胶是一种亲水性聚合物网络，可以吸收大量的水或生物液体，同时保持其结构。水凝胶模仿天然细胞外基质，可以封装细胞和药物，达到持续、局部释放。基于水凝胶的传输的优点包括保护药物免于降解、控制释放动力学以延长治疗活性、改善位点特异性靶向性以及与生物系统的兼容性。业界正在积极研究各种药物的水凝胶配方以及组织工程、创伤治疗和生物感测领域的新应用。
市场动态：
基于水凝胶的药物传输系统市场主要受到对局部和持续药物传输日益增长的需求的推动。水凝胶能够以控制释放的方式在较长时间内将药物定向输送到疾病部位，从而提高患者的依从性和治疗效果。这促使了对新型水凝胶系统的研究。透过使用水凝胶，可以克服传统剂型的限制。然而，高昂的研究成本和医疗核准规定限制了市场的成长。利用响应外部触发的先进聚合物技术，可以开发出更先进的水凝胶。应用范围正在扩展到 3D 细胞培养、植入和农业化学品输送。
本研究的主要特点
本报告对全球基于水凝胶的药物输送系统市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球水凝胶基药物输送系统市场的关键参与者根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行分析。
主要企业包括 Ocular Therapeutix, Inc.、Medtronic、Ferring BV、Pfizer, Inc.、Teva Pharmaceutical Industries Ltd.、ProLynx Inc.、Neurelis, Inc.、Micropore Technologies 和 Bausch Health Companies Inc.
本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
本研究报告研究了全球基于水凝胶的药物输送系统市场，并提供给该行业的各个相关利益者，例如投资者、相关人员、产品製造商、经销商、新进业者和财务分析师。
相关人员将透过用于分析全球水凝胶药物输送系统市场的各种策略矩阵来做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
4. 全球以水凝胶为基础的药物传递系统市场，依来源划分，2020-2032 年（十亿美元）
- 自然的
- 合成
- 杂交种
5. 全球以水凝胶为基础的药物传递系统市场，按应用划分，2020-2032 年（十亿美元）
- 心臟病学
- 肿瘤学
- 免疫学
- 疼痛管理
- 其他的
6. 全球以水凝胶为基础的药物传递系统市场，以输送途径，2020-2032 年（十亿美元）
- 皮下
- 眼科
- 口服
- 外用
- 其他的
7. 2020 年至 2032 年全球基于水凝胶的药物输送系统市场（按最终用户划分）（十亿美元）
- 医院
- 专科门诊
- 其他的
8. 2020 年至 2032 年全球基于水凝胶的药物输送系统市场，按地区划分，价值（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第九章 竞争格局
- Ocular Therapeutix, Inc.
- Medtronic
- Ferring BV
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
第 10 章分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第 11 章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global Hydrogel-Based Drug Delivery System Market is estimated to be valued at USD 8.49 Bn in 2025 and is expected to reach USD 13.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 13.47 Bn |
Hydrogel-based drug delivery system is an emerging technology that involves the use of hydrogels as a carrier for drug encapsulation and delivery. Hydrogels are hydrophilic, polymeric networks that can absorb large amounts of water or biological fluids, but maintain their structure. They mimic the natural extracellular matrix and can encapsulate cells and drugs to be released in a sustained and localized manner. Advantages of hydrogel-based delivery include protection of drugs from degradation, controlled release kinetics that prolong therapeutic activity, better targeting to specific body sites, and compatibility with biological systems. Industries are actively researching hydrogel formulations for various drugs and new applications in tissue engineering, wound healing, and biosensing.
Market Dynamics:
The hydrogel-based drug delivery system market is primarily driven by the rising demand for localized and sustained drug delivery. Hydrogels allow targeted delivery of drugs to disease sites in a controlled release manner over extended periods, improving patient compliance and treatment outcomes. This fosters research into novel hydrogel systems. Limitations of conventional dosage forms can be overcome by using hydrogels. However, high research costs and medical approval regulations restrain market growth. Opportunities lie in developing sophisticated hydrogels using advanced polymer technology, responding to external triggers. Applications are expanding into 3D cell culture, implants, and agrochemical delivery.
Key Features of the Study:
This report provides in-depth analysis of the global hydrogel-based drug delivery system market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hydrogel-based drug delivery system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Ocular Therapeutix, Inc., Medtronic, Ferring B.V., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., ProLynx Inc., Neurelis, Inc., Micropore Technologies, Bausch Health Companies Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hydrogel-based drug delivery system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydrogel-based drug delivery system market
Market Segmentation
- By Source Insights (Revenue, USD Bn, 2020 - 2032)
- Natural
- Synthetic
- Hybrid
- By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cardiology
- Oncology
- Immunology
- Pain Management
- Others
- By Route of Delivery Insights (Revenue, USD Bn, 2020 - 2032)
- Subcutaneous
- Ocular
- Oral
- Topical
- Others
- By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty clinics
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Ocular Therapeutix, Inc.
- Medtronic
- Ferring B.V.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Hydrogel-Based Drug Delivery System Market, By Source
- Hydrogel-Based Drug Delivery System Market, By Application
- Hydrogel-Based Drug Delivery System Market, By Route of Delivery
- Hydrogel-Based Drug Delivery System Market, By End User
- Hydrogel-Based Drug Delivery System Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Hydrogel-Based Drug Delivery System Market, By Source, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Natural
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Hydrogel-Based Drug Delivery System Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ocular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Hydrogel-Based Drug Delivery System Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Hydrogel-Based Drug Delivery System Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Ocular Therapeutix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ferring B.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
